Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.
about
Personality, psychopathology, life attitudes and neuropsychological performance among ritual users of Ayahuasca: a longitudinal studyMetabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuascaMethodology for determining major constituents of ayahuasca and their metabolites in blood.LC/MS/MS analysis of the endogenous dimethyltryptamine hallucinogens, their precursors, and major metabolites in rat pineal gland microdialysate.The hallucinogenic world of tryptamines: an updated review.Neuropharmacology of N,N-dimethyltryptaminePotentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors.Nonlinear pharmacokinetics of 5-methoxy-N,N-dimethyltryptamine in mice.Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices.Safety and side effects of ayahuasca in humans--an overview focusing on developmental toxicology.Ayahuasca and cancer treatment.Metabolism and urinary disposition of N,N-dimethyltryptamine after oral and smoked administration: a comparative study.A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 β-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches.
P2860
Q21134103-DC290989-959B-4FB3-9B97-798250B2F9B7Q28264811-6AF87B05-0725-4AA7-B94C-3AC2896F7A13Q33944518-6D3CCBDF-4753-4FA3-A89A-12FAD399ADE1Q34359597-56104F0D-AB12-40BB-B946-C216D25D6E59Q34471834-4101CD7A-E61F-48D9-BCF0-029619476AB6Q34524116-7CF95AC0-26FE-496A-BA0E-CCC95A5E5D35Q35025821-16711FF8-B6C9-4091-B690-BFA0F98D2BC4Q35079542-79413E44-7A7C-4789-81A1-C567B07F30B2Q36844764-BA39C223-4372-48BB-B047-6D1430B04D74Q37988834-9F52175F-5030-41BC-A6FE-2C27F96301BEQ38009283-265EE9ED-95B7-4651-9946-0DDF48D0AEDBQ38105566-02817B11-2784-4189-BBC6-EAA95F6B59FEQ38697611-1D32BB17-FEFB-4518-A1CF-A504FD1A535CQ50464203-23385334-D787-4CBC-A837-AAE4EE801BEAQ54671966-5BA74654-A7AF-4471-AD35-9BC9429174EC
P2860
Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine.
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Methodology for and the determ ...... cine ayahuasca in human urine.
@ast
Methodology for and the determ ...... cine ayahuasca in human urine.
@en
type
label
Methodology for and the determ ...... cine ayahuasca in human urine.
@ast
Methodology for and the determ ...... cine ayahuasca in human urine.
@en
prefLabel
Methodology for and the determ ...... cine ayahuasca in human urine.
@ast
Methodology for and the determ ...... cine ayahuasca in human urine.
@en
P2093
P2860
P356
P1476
Methodology for and the determ ...... icine ayahuasca in human urine
@en
P2093
Ethan H McIlhenny
Manel J Barbanoj
Rick Strassman
Steven A Barker
P2860
P304
P356
10.1002/BMC.1551
P50
P577
2010-11-05T00:00:00Z